David C. Eubanks

Statistics

Publications

Citations

145

H-Index

Active since

1981

Affiliations

Green Tech Labs (United States)(Current)

David C. Eubanks is an author at Green Tech Labs (United States) specializing in muscarinic receptor pharmacology, receptor pharmacology, and pharmacology.

Publications per year

1981–1998

Publications

An archaebacterial 5S rRNA contains a long insertion sequence

Kenneth R. Luehrsen, Diarmuid E. Nicholson, David C. Eubanks et al. · Nature · 1981 · 46 citations

Life Sciences, Microbiology, Molecular Biology +11

Design and Synthesis of m1-Selective Muscarinic Agonists: (R)-(−)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3‘-Methoxyphenyl)-2-propynyl)- oxime Maleate (CI-1017), a Functionally m1-Selective Muscarinic Agonist

Haile Tecle, Stephen D. Barrett, David Lauffer et al. · Journal of Medicinal Chemistry · 1998 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

High Throughput Assays of Cloned Adrenergic, Muscarinic, Neurokinin, and Neurotrophin Receptors in Living Mammalian Cells

Terri Messier, Christine M. Dorman, Hans Bräuner‐Osborne et al. · Pharmacology & Toxicology · 1995 · 26 citations

Medicine, Pharmacology, Cell Signaling +13

Characterization of in vitro DNA breakage and crosslinking induced by bis(isopropylamine)-trans-dihydroxy-cis-dichloroplatinum(IV)

Seymour Mong, David C. Eubanks, Archie W. Prestayko et al. · Biochemistry · 1982 · 23 citations

Life Sciences, Chemical Biology, Molecular Biology +16

In vitro and in vivo evaluation of the subtype-selective muscarinic agonist PD 151832

Juan C. Jaén, Stephen D. Barrett, Mark R. Brann et al. · Life Sciences · 1995 · 21 citations

Medicine, Medicinal Chemistry, Pharmacology +13

1–5 of 5